PHARMACEUTICAL COMPOSITION

PROBLEM TO BE SOLVED: To provide forms and formulations of VX-950 having improved bioavailability relative to crystalline VX-950.SOLUTION: Amorphous VX-950, for example the VX-950 that is substantially free of impurities and/or crystalline VX-950 is provided. Pharmaceutical formulations containing t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CUI YONG, MURPHY MAURA, CONNELLY PATRICK R, HURTER PATRICIA, PANICUCCI RICCARDO N, DINEHART KIRK
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide forms and formulations of VX-950 having improved bioavailability relative to crystalline VX-950.SOLUTION: Amorphous VX-950, for example the VX-950 that is substantially free of impurities and/or crystalline VX-950 is provided. Pharmaceutical formulations containing the VX-950 in the amorphous form used for treating hepatitis C virus are also provided.